Document Detail


Systemic combination treatment for psoriasis: a review.
MedLine Citation:
PMID:  20574597     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Psoriasis is a chronic inflammatory skin disease, which affects approximately 2.6% of the population in Northern Europe and Scandinavia. In order to achieve disease control, combinations of systemic treatments are sometimes needed for variable time periods. However, no evidence-based guidelines exist for the use of systemic combination therapy. Therefore, our aim was to review the current literature on systemic anti-psoriatic combination regimens. We searched PubMed and identified 98 papers describing 116 studies (23 randomized) reporting on the effect of various systemic combination treatments. The most thoroughly investigated combination was retinoid and phototherapy. Further controlled research is needed to define the safest and most effective combination regimens.
Authors:
Peter Jensen; Lone Skov; Claus Zachariae
Related Documents :
14758777 - Onercept. serono.
6225077 - Diseases of the nails. how to recognize and treat them.
8006427 - Epidemiology of psoriasis: clinical issues.
22544647 - Inflammation and α-synuclein's prion-like behavior in parkinson's disease-is there a l...
14534797 - Diameter of mammary terminal ducts as an additional tool in evaluation of women with po...
7616227 - Transferrin and iron in normal, alzheimer's disease, and parkinson's disease brain regi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Acta dermato-venereologica     Volume:  90     ISSN:  1651-2057     ISO Abbreviation:  Acta Derm. Venereol.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-24     Completed Date:  2010-10-12     Revised Date:  2012-01-02    
Medline Journal Info:
Nlm Unique ID:  0370310     Medline TA:  Acta Derm Venereol     Country:  Sweden    
Other Details:
Languages:  eng     Pagination:  341-9     Citation Subset:  IM    
Affiliation:
Department of Dermato-Allergology, Copenhagen University Hospital Gentofte, Denmark. peterj01@geh.regionh.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Agents / therapeutic use
Cyclosporine / therapeutic use
Dermatologic Agents / therapeutic use*
Drug Therapy, Combination
Evidence-Based Medicine
Humans
Methotrexate / therapeutic use
Photochemotherapy*
Photosensitizing Agents / therapeutic use*
Psoriasis / drug therapy*
Retinoids / therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
0/Biological Agents; 0/Dermatologic Agents; 0/Photosensitizing Agents; 0/Retinoids; 59-05-2/Methotrexate; 59865-13-3/Cyclosporine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The impact factor leaps again!
Next Document:  Ceramides and barrier function in healthy skin.